These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 7447117)

  • 21. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bioavailability and elimination of various digoxin preparations in the beagle dog and their possible sex dependence (author's transl)].
    Gastauer R; Eltze M; Pabst J
    Arzneimittelforschung; 1979; 29(5):754-7. PubMed ID: 582973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of digoxin from tablets. II. Radioimmunoassay and disposition pharmacokinetics of digoxin after intravenous administration.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):459-70. PubMed ID: 4440504
    [No Abstract]   [Full Text] [Related]  

  • 24. Digoxin pharmacokinetics and dosage requirements in pediatric patients.
    Bendayan R; McKenzie MW
    Clin Pharm; 1983; 2(3):224-35. PubMed ID: 6349908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability and pharmacokinetics of intravenously and orally administered allopurinol in healthy beagles.
    Bartges JW; Osborne CA; Felice LJ; Koehler LA; Ulrich LK; Bird KA; Chen M; Sawchuk RJ
    Am J Vet Res; 1997 May; 58(5):504-10. PubMed ID: 9140559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of single doses of digoxin administered intravenously to ducks, roosters, and turkeys.
    Pedersoli WM; Ravis WR; Lee HS; Krista LM; Spano JS
    Am J Vet Res; 1990 Nov; 51(11):1751-5. PubMed ID: 2240800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
    Dohoo SE; Tasker RA
    Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of gentamicin in dogs after intramuscular or subcutaneous injections.
    Wilson RC; Duran SH; Horton CR; Wright LC
    Am J Vet Res; 1989 Oct; 50(10):1748-50. PubMed ID: 2802306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
    Batzias GC; Delis GA; Athanasiou LV
    Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of thiamphenicol in dogs.
    Castells G; Intorre L; Franquelo C; Cristòfol C; Pérez B; Martí G; Arboix M
    Am J Vet Res; 1998 Nov; 59(11):1473-5. PubMed ID: 9829409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium.
    Le Traon G; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Apr; 31(2):95-101. PubMed ID: 18307500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The pharmacokinetics and bioavailability of acepromazine in the plasma of dogs].
    Hashem A; Kietzmann M; Scherkl R
    Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):396-8. PubMed ID: 1425314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of three formulations of diphenylhydantoin in the dog.
    Overduin LM; van Gogh H; Mol JA; van Nes JJ
    Res Vet Sci; 1989 Mar; 46(2):271-3. PubMed ID: 2704892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
    Bochner F; Huffman DH; Shen DD; Azarnoff DL
    J Pharm Sci; 1977 May; 66(5):644-7. PubMed ID: 874745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of luxabendazole after oral and intravenous administration to sheep.
    Ortiz AI; Alvarez-Bujidos L; Ferre I; Ordóñez D
    Am J Vet Res; 1997 Nov; 58(11):1263-6. PubMed ID: 9361890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.